| Pregabalin | Duloxetine |  | ||
---|---|---|---|---|---|
 | N = 446 | N = 446 |  | ||
 | n | % | n | % | P value* |
Age, years (categorical) | Â | Â | Â | Â | 0.1304 |
18-29 | 0 | 0.0 | 0 | 0.0 | Â |
30-39 | 7 | 1.6 | 1 | 0.2 | |
40-49 | 27 | 6.1 | 26 | 5.8 | |
50-59 | 73 | 16.4 | 86 | 19.3 | |
60-69 | 144 | 32.3 | 159 | 35.7 | |
70-79 | 150 | 33.6 | 126 | 28.3 | |
80-89 | 45 | 10.1 | 48 | 10.8 | |
Gender | Â | Â | Â | Â | 0.5854 |
Male | 185 | 41.5 | 177 | 39.7 | Â |
Female | 261 | 58.5 | 269 | 60.3 | |
Race/Ethnicity | Â | Â | Â | Â | 0.7265 |
White | 363 | 81.4 | 353 | 79.1 | Â |
Black | 58 | 13.0 | 69 | 15.5 | |
Hispanic | 13 | 2.9 | 14 | 3.1 | |
Other | 12 | 2.7 | 10 | 2.2 | |
Geographic Region | Â | Â | Â | Â | 0.6759 |
Northeast | 5 | 1.1 | 5 | 1.1 | Â |
Midwest | 78 | 17.5 | 78 | 17.5 | |
South | 338 | 75.5 | 333 | 74.7 | |
West | 25 | 5.6 | 30 | 6.7 | |
Low Income Status | 87 | 19.5 | 92 | 20.6 | 0.6814 |
Dual Eligibility Status | 52 | 11.7 | 56 | 12.6 | 0.6759 |
 | Mean | SD | Mean | SD |  |
Age, years (continuous) | 66.7 | 10.7 | 66.7 | 10.4 | 0.5924 |
Propensity Score | 0.47 | 0.14 | 0.47 | 0.14 | 0.9931 |